Octagam® 10%

(HUMAN NORMAL IMMUNOGLOBULIN, SOLUTION FOR INTRAVENOUS INFUSION)

Octagam® 10% is an immunoglobulin for intravenous use, which is used for replacement therapy in primary and secondary immunodeficiency and for immunomodulation associated with certain autoimmune diseases. Octagam® 10% is a ready-to-use solution available in Australia as a 10% concentration.

For more information, review the Australian Approved Product Information available here.

You are now on the Octapharma Australia website.

If you are from another country, visit the global Octapharma website and select your relevant local country to review your country-specific information.

To contact your local Octapharma Australia team click here

Are you a Health Care Practitioner (HCP)?

Are you a Health Care Practitioner (HCP)?

Cookie settings

Here you can choose your preferences. Click on the different categories to find out more. Please note that blocking some of the cookies may impact you web experience.

Without this cookies, the website cannot perform basic functions. They may be set automatically when pages load, or as a result of a user request that cannot be fulfilled without the use of the cookie.

These cookies allow our website to remember choices you make while browsing. For instance, we may store your geographic location in a cookie to ensure that we show you our website localized for your area.

We use Google Analytics to collect information about how our visitors use and navigate our site. We use this information to report and analyse the usage of the site with the intention to improve the usage of the homepage for visitors.

Find more information in our Data Privacy Statement.

You are now leaving

You are now leaving Octapharma.com.au

The website or information you are about to access may not comply with Australian regulatory requirements. For Australian relevant information please refer to or contact Octapharma Australia.

To return to the prior page, please select cancel.

To continue to the offsite link, please select continue.